Key points are not available for this paper at this time.
This abstract is part of my collaboration with my mentor in the ISN mentorship program. Diabetic nephropathy represents a significant contributor to end-stage kidney disease (ESKD). Among the numerous cytokines implicated in the development of diabetic nephropathy, one of paramount importance is transforming growth factor beta-1 (TGF-β1). Its primary function lies in facilitating the deposition of extracellular matrix. Diabetic nephropathy typically presents with elevated renal levels of TGF-β1, and the measurement of its urinary excretion can serve as a valuable indicator for predicting outcomes.
Kulkarni et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: